The O-linked glycosylation of the main acidic high-molecular-weight glycoprotein from ascites fluid from patients with ovarian cancer were analyzed. The O-linked oligosaccharides were shown to consist of mainly highly sialylated core 1 and 2 structures with a smaller amount of sulfated core 2 structures. These structures were shown to be able to be further extended into small keratan sulfate (KS)-type oligosaccharides with up to four N-acetyllactosamine units. Proteomic studies of the acidic fraction of ascites fluid from patients with ovarian cancer showed that this fraction was enriched in proteoglycans. Among them, lumican, agrin, versican and dystroglycans were potential candidates, with threonine-and serine-rich domains that could carry a significant amount of O-linked glycosylation, including also the O-linked KS. Glycomic analysis using liquid chromatography (LC)-tandem mass spectrometry (MS/MS) also showed that the disialic acid NeuAc-NeuAcwas frequently found as the terminating structure on the O-linked core 1 and 2 oligosaccharides from one ascites sample. Also, a small amount of the epidermal growth factor (EGF)-associated O-linked fucose structure GalGlcNAc-Fucitol was detected with and without sialic acid in the LC-MS/MS analysis. Candidate proteins containing O-linked fucose were suggested to be proteoglycan-type molecules containing the O-linked fucose EGF consensus domain.
Introduction
O-Linked glycosylation is one of the most ubiquitous and most important post-translational modifications of proteins and is connected to the biological roles such as fertilization (Pang et al. 2011) , cancer (Brockhausen 2006 ) and inflammation (McEver 1997; Estrella et al. 2010) . Studying the O-linked glycome is essential for making the connections between structure and function and how an altered glycosylation machinery participates in disease etiology. These connections will also provide the biological relevance for glycobiomarker discovery and the cataloguing of oligosaccharide structures on complex glycoproteins that is now possible using mass spectrometry-based techniques. O-Linked oligosaccharides are mostly known in the area of mucins, where mucosal surfaces are protected by heavily glycosylated (up to 80% of the weight) proteins belonging to the mucin family (MUC1-20), constituting the major macromolecular component of mucus and the mucosal apical glycocalyx (Lindén et al. 2008) . The mucin-type glycosylation is initiated in the Golgi/endoplasmic reticulum (ER) by the attachment of GalNAc to Ser or Thr residues by a family of GalNAc transferases (Tarp and Clausen 2008 ). The GalNAc moieties are then further extended on the C-3 and C-6 carbon by N-acetyllactosamine (LacNAc) extensions and/or terminated by blood group antigens, sialylation and sulfation. The mucintype glycosylation is also prevalent on many other secreted glycoproteins that are synthesized in the ER and Golgi and secreted via the classical secretory pathway. The plasma O-linked oligosaccharides are dominated by short sialylated structures (sialyl and di-sialyl-T; Wilson et al. 2002) , whereas, for instance, O-linked keratan sulfate (KS) proteoglycans in the extracellular matrix consist of extended poly-sulfated poly-LacNAc oligosaccharides (Zaia 2009) .
Although alteration in O-linked glycosylation is one of the hallmarks for cancer, this is usually accompanied by an altered differentiation state and environment of the cancer cells. These alterations may not only be regulated by the genome via altered expression of glycosyltransferase and mucin genes, but also due to an altered Golgi apparatus and secretory pathway (Axelsson et al. 2001; Gill et al. 2010 ). Ovarian cancer is one of the cancers with highest incidence and fatalities in the Western world, and early detection of ovarian cancer is one of the key factors for successful treatment. The mucin MUC16 measured as CA125 is the gold standard for monitoring the efficacy of ovarian cancer therapy (Karam and Karlan 2010) , but its use in ovarian cancer screening diagnosis has not been successful due to its low specificity. Other glycosylation-dependent markers, such as CA19.9, CA50 and CA242, are also used as serum markers for cancer (Chauhan et al. 2009 ). Most of these assays are based on the antibody recognition of the oligosaccharide structures without distinction between different glycoproteins on which they may be carried. N-Linked glycosylation expressing sialyl-Lewis x on common plasma proteins has also been suggested to increase the sensitivity of ovarian cancer diagnostics (Saldova et al. 2008) . Despite the potential of a combined protein/oligosaccharide for the diagnosis of ovarian cancer, the methodology to identify glycobiomarkers is not straightforward, and only dedicated glycoanalytical research groups are successfully pursuing this pathway. This point is exemplified by the only detailed characterization of oligosaccharides from the ovarian cancer antigen CA125 being restricted to ovarian cell lines (Kui Wong et al. 2003) , whereas the knowledge of O-linked glycosylation of CA125 from primary ovarian cancers is currently based only on lectin/antibody recognition.
We have developed a platform for the analysis of O-linked oligosaccharides based on the isolation of high-molecularweight acidic glycoproteins and analysis using negative-ion graphitized carbon liquid chromatography (LC) coupled to mass spectrometry . This platform has been shown to address the questions of individual variation in glycosylation (Thomsson et al. 2005) as well as identifying disease-related differences in O-linked glycosylation in cystic fibrosis (Holmén et al. 2004; Schulz et al. 2004 Schulz et al. , 2007 , ulcerative colitis (Larsson et al. 2011) and differences in glycosylation between rheumatoid arthritis and osteoarthritis (Estrella et al. 2010) . Using this platform, we set out to address the O-linked glycosylation of large glycoproteins present in the ascites from one patient with papillary serous adenocarcinoma. Using this result, we also queried other ovarian cancer ascites samples to identify commonalities in O-linked glycosylation and the secreted glycoproteome.
Results
Sialylated oligosaccharide detected from acidic high-molecular-weight proteins of ovarian cancer ascites Acidic proteins from ascites from a patient with papillary serous adenocarcinoma (SER8, Supplementary data, Tables S1 and S2, Figure S1 , CA125 negative) were isolated by anion-exchange chromatography. In order to identify sialylated and/or sulfated high-molecular-mass glycoproteins, the acidic proteins from DEAE Sephadex were subjected to sodium dodecyl sulfate-polyacrylamide/agarose composite gel electrophoresis (SDS-AgPAGE), where mucins and other large glycoproteins from 100 kDa to 10 MDa can be separated . One major band with an apparent mass of >1 MDa was detected using Alcian blue (Figure 1 ), indicating that there were highly acidic oligosaccharides present, containing either sialic acid, sulfate or both. This observation could be verified after subjecting this region of the gel to reductive β-elimination and analyzing released oligosaccharides by LC-tandem mass spectrometry (MS/MS). It was found that the LC-MS profile was dominated by mono-and disialylated core 1 structures ([M-H] O-Linked glycome and proteome in ovarian cancer ions of m/z 1331/666; Table I ). Low-intense, low-molecular mass ions were also detected ([M-H] − ion of m/z 513), which the MS/MS fragmentation showed corresponded to the sialyl-Tn structure NeuAcα2-6GalNAcol (Table I ). There were no compositions of mucin-type fucosylated structures detected. This indicated that previously described cancerassociated fucose-containing oligosaccharide structures, such as sialyl-Lewis x or sialyl-Lewis a (CA19-9), were not major components of the O-linked oligosaccharides in the major high Mr component of this sample.
In order to confirm the sequence of the intense core 2 structure, the sample was desialylated and the dominating [M-H] − ion of m/z 749 in the chromatogram ( Figure 1C ), corresponding to the sequence of a core 2, type 2 tetrasaccharide Galβ1-4GlcNAcβ1-6(Galβ1-3)GalNAcol, was identified by MS/MS (Figure 2 ).
Sulfation of human ascites oligosaccharides
Having identified that the dominating peaks of the oligosaccharides released from the >1 MDa Alcian blue stained band ( Figure 1A ) were sialylated core 1 and 2 structures, LC-MS/ MS of the minor components showed that ovarian cancer ascites oligosaccharides also contained parent ions corresponding to sulfated structures such as the Figure 3B ) of this ion confirmed that this was a core 2 tetrasaccharide modified by sulfation (Table I ). The location of sulfate was shown to be on the GlcNAc on the C-6 branch of the GalNAcol, indicated by the fragment Y 1α /Y 1β of m/z 505 and Y 1α /C 1α or Z 1α /B 1α οf m/z 282.
Further analysis of the of the LC chromatogram showed that the disialylated sulfated core 2 structure (
− ion pair of m/z 1411/706) was the first structure in a series of structures extended by sulfated LacNAc units (Figure 4 ). Doubly charged ions displayed a complex sulfation of core 2 structures extended with up to three LacNAc units, with the maximum sulfation of one sulfate per LacNAc unit. This indicated that, rather than classical mucin-type oligosaccharides, the glycosylation of this sample were extended into shorter KS-type structures. The sulfation attached to GlcNAc in the first structure of this series further strengthens this argument, since KS is dominated by 6-linked sulfate to GlcNAc. Due to the low intensity of the [M-2H] 2− ions in Figure 4B -D, the fragmentation could confirm that it was consistent with the assigned monosaccharide composition, but the sites of sulfation could not be identified. NeuAcα2-Galβ1-3(NeuAcα2-Galβ1-4(HSO 3 -6)GlcNAcβ1-6)GalNAcol + NeuAc 21.4 0.1 1257
Associated fragment spectra were submitted to Unicarb-DB (Hayes et al. 2011; www.unicarb-DB.com ).
a Linkage configuration and position based on core 1, 2 and 3 series of extension. Type 2 configuration Galβ1-4GlcNAcβ1-is based on the detection of linkage-specific MS/MS fragment of desialylated structures. Six-linked sialic acid assigned from the detection of sialic acid directly linked to GalNAc. Sulfation is assumed to be C-6 on GlcNAc residues. C-6 branch of GalNAcol is bold to help reading of sequences.
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Detection of the NeuAc-NeuAc motif in human ascites oligosaccharides With sensitive detection of oligosaccharides by LC-MS, the method is also capable of detecting less common O-linked motifs. Selected fragment ion MS/MS chromatograms showed that the theoretical negative-ion B 2 fragment of m/z 581 of two sialic acids linked together was present in the sample. MS/MS were generated of two structures corresponding to a trisialylated core 1 structure of Figure 5A ). Both these parent ions gave intense B 2 fragment ions of m/z 581 ( Figure 5B and C). After desialylation, the HSO 3 -NeuAc 3 Hex 2 HexNAc 3 structure was shown to have the same core as the one described in the beginning of this section, since only one isomer of the [M-H] − ion of m/z 829 corresponding to the desialylated sulfated core 2 could be detected. These data indicate that the disialic acid motif was an extension of the sialylated structures present in high abundance in the sample (Table I) and was a common motif in this sample ( Figure 5A ).
In order to investigate the involvement of disialylation on the surface of ovarian cancer cells, the presence of O-linked oligosaccharides from ovarian cancer tissue was investigated after the enrichment of membrane-associated proteins (Pedersen et al. 2003) . The enrichment of membrane proteins and release of O-linked oligosaccharides from a patient with ovarian cancer showed that the disialic motif was also present on the ovarian cancer cell membranes, and not only secreted into the ascites. Among unsulfated core 1 structures (major components) and core 2 structures (minor components) ), low-intense ions corresponding to the trisialylated core 1 structure were detected and the MS/MS confirmed the presence of the disialic motif ( Figure 5 ). This structure has the same sequence as the core 1 O-linked oligosaccharide containing the disialic acid motif identified on human glycophorin (Fukuda et al. 1987) . A fragment of m/z 281 and 0,2 A -H 2 O of m/z 263 shown to be specific for the type 2 (Galβ1-4GlcNAc) and not type 1 (Galβ1-3GlcNAc) chains is specifically labeled in (B).
O-Linked glycome and proteome in ovarian cancer
Identification of O-linked fucose-type oligosaccharide Although there was no indication of fucose linked to mucintype O-linked structures, another type of fucosylation was detected. Low-intense [M-H] − ions with m/z 530 and 821 were detected (Table I ) among the mucin-type oligosaccharides released by reductive β-elimination. The lower mass corresponded to a composition of an alditol with one fucose, one hexose and one N-acetylhexosamine (HexNAc), whereas the higher was the sialylated version of this. Closer examination of the LC-MS/MS spectrum of the [M-H] − ions with m/z 530 ( Figure 6 ) identified the structure. Despite the low intensity of this parent ion providing noisy fragmentation data, the fucose could be deduced to be located at the reducing end as a fucitol. Abundant fragment ions from the fragmentation of glycosidic linkages could be identified, providing a collision spectrum previously reported for the sequence Hex-HexNAc-Fucitol (Wilson et al. 2008) , despite the presence of high-abundant unassigned ions (i.e. m/z 327.0, 339.1 and 415.9), believed to be due to the background noise. The assignment of this structure showed that not only O-linked mucin-type oligosaccharides were present, but also the epidermal growth factor (EGF)-type O-linked fucose (Luther and Haltiwanger 2009) , which is usually found attached to low-mass proteins containing EGF domains. However, it has also been shown to be present on high-molecular-mass proteins in human breast milk fat globular membranes and its sialylated version in bovine milk (Wilson et al. 2008) . The identification of the unsialylated structure in the fraction of high-molecular-mass acidic proteins in ascites indicates that despite not being negatively charged itself, it must be associated with an acidic protein carrier. This suggests that the proteins carrying this epitope also are likely to carry high amounts of sialic acid and sulfate, present on proteins such as mucins or proteoglycans. So far, the consensus sequence for O-linked fucose has not been found to be present within EGF domains of mucins, but it is present in some proteoglycans (see section Identification of proteoglycan core proteins in ovarian cancer ascites).
Screening of oligosaccharide epitopes in ovarian cancer samples Having identified both core 1 and 2 structures in human ascites, additional ovarian cancer ascites samples were screened for these types of oligosaccharides by LC-MS, and it was found that the dominating structures identified in the original sample were also found in all the additional samples (Table II) . This shows that the core 1 and 2 structures are ubiquitous in ovarian cancer ascites. In order to investigate the 
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incidence of sulfation, the [M-H] − ion of m/z 1120 (Galβ1-3 (Galβ1-4(HSO 3 -6)GlcNAcβ1-6)GalNAcol + NeuAc) was also screened in all the samples. This showed that also sulfation was a common feature of the ovarian cancer ascites, since it was successfully detected in 18 of the 20 samples analyzed. In the remaining two, the presence of sulfated oligosaccharides cannot be ruled out, since the overall MS signal of oligosaccharides in these two samples were low, rendering the detection of sulfated oligosaccharides to be below the detection limit.
CA125/MUC16 in ovarian cancer ascites
Since CA125/MUC16 is a common mucin marker for ovarian cancer, it was investigated how the identified oligosaccharides were connected to CA125. In 17 of the 24 samples investigated, CA125 activity was detected in the highmolecular-mass region >1 MDa after SDS-AgPAGE and western blotting (Table II and Supplementary data, Figure S1 ). Samples with absent, low and high CA125 activity were also subjected to in-gel digestion and LC-MS/MS identification using a protein database consisting of known human mucins, in order to specifically identify mucins in the samples. In four samples, we found peptides from mucin apoproteins (MUC16, MUC5B and MUC1; Table II and  Supplementary data, Table S3 ). The highest incidence of peptides was a patient diagnosed with benign serous cystadenoma, where both MUC5B (five peptides) and MUC16 (eight peptides) were identified. This patient was also found to have the highest amount of CA125/MUC16 activity by western blotting. In one sample, MUC16 was identified by LC-MS, where there was no CA125 immunoreactivity. MUC1 (two O-Linked glycome and proteome in ovarian cancer peptides) was also found in one patient diagnosed with papillary serous cystadenocarcinoma. Mucins are usually difficult to digest with trypsin and other proteases due to their extensive glycosylation. This has been shown for instance for MUC16 isolated from an ovarian cancer cell line (Yin and Lloyd 2001) . The higher sensitivity of western blotting compared with LC-MS can explain the discrepancy between techniques for the detection of CA125/MUC16. This indicates that also the other mucins detected by LC-MS will be more consistently detected by western blotting.
Identification of proteoglycan core proteins in ovarian cancer ascites
In the proteomic analysis, it was found that peptides matched to apomucins only corresponded to a minor fraction of all Inserted are selected ion chromatograms of each ion from ascites (B) and cancer tissue (C), respectively. Oligosaccharide alditol compositions are referred to as (Hex, HexNAc, NeuAc, sulfate).
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peptides identified in the total acidic fraction. Analysis of the acidic proteins from human ascites from patients with ovarian cancer indicated that the mucin component of the sample is often only a minor constituent. In the sample analyzed thoroughly for glycosylation (Figure 1 ), we found that there were significant O-linked glycosylation, without any major mucin apoprotein identified by LC-MS or by western blotting (MUC16). The presence of KS-like sulfation indicated that one potential candidate for the presence of sulfated O-linked oligosaccharides is that they are attached to KS proteoglycantype apoproteins. High-molecular-mass proteins from three of the samples were separated by SDS-AgPAGE and the area from 100 kDa to 2 MDa was cut into pieces. After trypsin digestion and LC-MS/MS of pieces cut out after SDSAgPAGE, 10 proteoglycan-type apoproteins were identified, together with a large number of additional acidic proteins identified by their peptides (Table III) . Interrogating the UniProt database to ascertain whether these proteins are known to contain O-linked oligosaccharides, only identified lumican to have consistently been shown to contain O-linked KS. However, proteins, such as agrin, versican and dystroglycan, contain extended stretches in their amino acid sequence rich in serine, threonine and proline, where extensive O-linked glycosylation is expected. This makes them potential candidates for the sulfated and unsulfated O-linked oligosaccharides identified in the samples, in addition to the mucins identified in Table II .
Discussion
Identification and characterization of high-molecular-weight acidic proteins from ovarian ascites from patients using SDS-AgPAGE provides a platform complementary to twodimensional SDS-PAGE for biomarker discovery in this disease. Although mucins are believed to play an important role in ovarian cancer (e.g. CA125 and CA19-9), their importance may not necessarily be reflected in their abundances in ascites. Furthermore, their use as diagnostic markers could relate more to their immunogenicity and the historical use of antibodies and not MS to identify and measure markers. Mucins are not normally found at high concentrations in serum and hence serve as good markers in cancer. The detection of acidic proteins by Alcian blue provided distinct bands by SDS-AgPAGE, and most likely these bands consist of traditional mucins as well as mucin-type proteoglycans with short KS oligosaccharides. Identification of proteins in this high-molecular-weight region suggests that there are several candidates other than mucins that carry O-linked glycans (Table III) . From the estimated size of classical O-linked KS chains (KSII) from articular cartilage, the number of LacNAc repeats detected here (Figure 4 ) is in the low end of the range (Funderburgh 2000) . However, with novel techniques developing for studying glycosylation, distinguishing KSII from sulfated O-linked will become arbitrary and the poly-prefix of the LacNAc chain will be converted into a direct and correct display of individual polymer/oligomer chains.
The oligosaccharides from ovarian cancer ascites are in many ways unique compared to other mucin-type oligosaccharides investigated to date. They do not contain any fucose common on the mucins found on mucosal surfaces, often as blood group antigens from the ABO and/or Lewis system. Hence, they are more related to the glycosylation of constitutively highly expressed glycoproteins in human plasma. Functionally, this could be related to the non-mucosal nature of the mesothelial/ovarian surface, i.e. it is internal rather than exposed to microbial flora. However, the sulfation of plasma glycoproteins is rare. The lack of fucosylation is also likely to make the detected oligosaccharides a poor target for L-selectin, or any of the other selectins (McEver 1997). Other lectins targeting sulfated compounds, such as siglec-8 (Hudson et al. 2009 ) and galectin-8 (Ideo et al. 2011) , also have different additional structural requirements to what we report in ovarian cancer. This indicates that the sulfation of ascites fluid in ovarian cancer represent a novel biological function. If this function has an effect on the cancer development, oligosaccharide sulfation may serve as a diagnostics for ovarian cancer detection or for monitoring ovarian cancer therapies. In regard to the other "exotic" oligosaccharide epitopes, the potential EGF-type glycosylation still needs further investigation. Many of the proteoglycan candidates in Table III contains EGF domains and also the specific O-fucose consensus sequence, making them potential candidates to carry O-linked fucose oligosaccharides, and explain why O-linked fucose was found among high-molecular-weight acidic glycoproteins. 
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The disialic acid epitopes could also represent an interesting opportunity as a biomarker and give insight into the cancer progression. The ability of ovarian mucin-type oligosaccharides to bind to siglecs (Crocker and Varki 2001) is still unexplored. In particular, Siglec-7 has been found to bind the disialic acid motif (Nicoll et al. 2003) . Binding to Siglec-7 could influence cancer progression by protecting from immune surveillance by natural killer (NK) cells expressing Siglec-7. Disialic acid motifs are frequently detected among glycosphingolipids, but less so among O-or N-linked oligosaccharides. Since the late pathway for the glycosylation of both N-linked, O-linked and glycosphingolipids are believed to utilize the same glycosylation machinery and enzymes, it is more than likely that the disialic acid motif is more ubiquitous among glycoproteins than expected previously. The analytical techniques for glycomics such as permethylation and MS (Kang et al. 2008; North et al. 2009; Prien et al. 2010) as well as the LC-MS of underivatized oligosaccharides as presented here have now reached the sophistication to identify this epitope on a more regular basis.
The data also indicate that O-linked KS is a significant component of the ovarian cancer ascites. This opens up the possibility to explore proteoglycans with extended mucin domains, such as lumican, agrin, versican and dystroglycan, for their role in ovarian cancer. Dystroglycan has also been shown to contain not only mucin-type O-linked oligosaccharides, but also O-mannose initiated oligosaccharides within its mucin domain (Stalnaker et al. 2011) . The MS/MS fragmentation positively confirmed the presence of reduced HexNAc (GalNAc) and deoxyhexose (Fuc), and the absence of reduced Hex (Man) showed that O-linked Man can only be a very minor contributor to the O-linked glycome in human ascites. The data in this report also show that additional proteoglycans are present, where only limited information about these types of molecules in ovarian tissue and their role in the biology of ovarian cancer are currently available. Accumulation of ascites fluid in ovarian cancer patients is due to shed ovarian cancer cells blocking the lymphatic drainage of the peritoneal cavity. The ectopic presence of mucins is a direct consequence of secretion directly into the peritoneal fluid. An increased amount of ascites can also more rarely occur in benign ovarian tumors, but in healthy individuals large volumes of fluid transit rapidly through the peritoneum. This investigation did not reveal any obvious qualitative differences between different subtypes of ovarian cancer or with benign disease (summarized in Supplementary data, Table S3 ), neither in respect of the type of mucins and their glycosylation nor the type of proteoglycans present. Instead, it provides a roadmap for quantitative analysis of the target molecule for further investigation. In order to further investigate the role of proteoglycans in ovarian cancer, glycomic and glycoprotemic analyses of cystic fluid and tumor tissue, where the cancer-related proteins are enriched, are likely to provide information about the origin of the proteoglycans and their role in ovarian cancer development.
Materials and methods

Enrichment of mucin-type oligosaccharides
Human ascites samples (0.5-1.0 mL) were diluted ×10 with 250 mM sodium chloride in 20 mM Tris/10 mM ethylenediaminetetraacetic acid (EDTA), 50 μL of protease inhibitors was added and the samples (Supplementary data, Tables S1 and S2) were injected to a diethylaminoethyl fast flow (DEAE FF) (1 mL) column (GE Healthcare, Uppsala, Sweden) run at 1.0 mL/min in the same solution. After loading (5-10 min), the columns were washed with 10 mL of the starting buffer and the retarded fraction was collected (10 mL) by increasing the sodium chloride concentration to 1.0 M. The proteins in the collected samples were precipitated with ethanol (80% final concentration) at −20°C for 12 h.
SDS-AgPAGE and SDS-PAGE
The acidic fraction from ascites were reduced in SDSAgPAGE sample buffer in 10 mM dithiothreitol (DTT) at 95°C
for 10 min and then alkylated with iodoacetamide (25 mM) for 1 h at room temperature. Samples was loaded (2-20 μL) and electrophoresed , blotted onto polyvinylidene fluoride (PVDF) membranes and stained with Alcian blue or developed by western blotting.
Identification of high-molecular-weight acidic glycoproteins from human ascites Protein identification was performed after tryptic digestion of proteins found in the region between 100 kDa and 2 MDa using LC-electrospray-MS/MS. (ThermoFinnigan, San Jose, CA). SEQUEST (fragmented peptide ion pattern matching, ThermoFinnigan) were used for database searching and protein identification using either the Uniprot human database or a smaller database of human mucins (MUC1-20) (http:// www.medkem.gu.se/mucinbiology/). Positive protein matches were assigned according to the criteria of at least two peptide sequences with the manual inspection of tandem mass spectra showing at least four consecutive b or y overlapping ions, an X corr of >2.0 and a ΔC n of >0.1.
Glycoprotein oligosaccharide profiling
Mucin glycosylation is predominantly O-linked and can constitute up to 80% of the total mucin molecular weight. O-Linked oligosaccharides were released from blots after separation using SDS-AgPAGE using reductive β-elimination as described and analyzed by LC-MS/MS using graphitized carbon chromatography (7 μL/min in a 300-μm ID × 100 mm column with 5 μm particles) and a gradient of water-acetonitrile in 10 mM ammonium bicarbonate. Oligosaccharides were injected (5 μL of a total of 10 μL) and detected with an Agilent XCT ion trap mass spectrometer (Santa Clara, CA) run in a negative mode, with smart fragmentation (90-120%) of the two most intense ions in each full scan. The remaining 5 μL of oligosaccharides were desialylated using 10 mU sialidase A (α2-3, α2-6, α2-8 and α2-9 specific) (Glyko, Novato, CA) according to the manufacturers' recommendation and incubated at 37°C for 16 h. The sample was desalted on homemade micro desalting columns ( 2 μL) containing Carbograph material (Alltech, Deerfield, IL) laid on the top of a reverse-phase μ-C18 ZipTip (Millipore, Bedford, MA; Karlsson et al. 2004 ) and subjected to LC-MS and LC-MS/MS as described in the beginning of this section. Detected oligosaccharides were sequenced based on the MS/ O-Linked glycome and proteome in ovarian cancer MS spectra and core-type linkage configuration were assumed based on cores 1-3, based on the substitution pattern of the reducing end GalNAcol and comparison with reference MS/ MS spectra. Sialic acid was assumed to be 6-linked, if it was found to be directly linked to the GalNAcol residue. Sulfation of the core 2 inner core was found to be on 6-position due to the positive identification of sulfated HexNAc. Sulfation further out of the LacNAc chain was not verified. The type 2 chain was assumed based on the positive identification of cross-ring fragments specific for the C-4 extension of HexNAc . Structures and associated fragment spectra were submitted to the Unicarb-DB depository (Hayes et al. 2011 ).
Western blotting
Human ascites blotted onto PVDF membranes was blocked in 1% bovine serum albumin in Tris-buffered saline-Tween (TBS-T) overnight at 4°C. The samples was then incubated with ab1107 (CA125/MUC16, 1/10,000) in the same buffer for 3 h and washed 3 × 10 min with TBS-T, before incubating (1 h) with horseradish peroxidase-labeled secondary antibody (1/10,000 for ab1107, 1/1000 for the other) in blocking solution. The blots were washed 5 × 20 min with TBS-T and developed using the western femto reagent (Pierce, Rockford, IL).
